Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT00006436
First received: November 3, 2000
Last updated: December 7, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: March 2021
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):